Anzeige
Mehr »
Login
Sonntag, 19.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
100-Milliarden-Dollar-Marke: Wie die strategische Vision eines Unternehmens historischem Meilenstein passt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A408BD | ISIN: VGG5214E1034 | Ticker-Symbol: K40
NASDAQ
17.01.25
21:42 Uhr
1,160 US-Dollar
+0,090
+8,41 %
Branche
Fahrzeuge
Aktienmarkt
ASIEN
1-Jahres-Chart
KANDI TECHNOLOGIES GROUP INC Chart 1 Jahr
5-Tage-Chart
KANDI TECHNOLOGIES GROUP INC 5-Tage-Chart
GlobeNewswire (Europe)
164 Leser
Artikel bewerten:
(1)

Kandi Technologies Group, Inc.: Kandi Technologies Appoints New CEO for SC Autosports

Finanznachrichten News

JINHUA, CHINA, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) ("Kandi" or the "Company"), a leading producer of all-electric personal transportation and utility vehicles, today announced that, following a thorough review and decision by its management team, Mr. Bin Yu has been appointed Chief Executive Officer (CEO) of SC Autosports (d/b/a Kandi America), the Company's U.S. subsidiary. This move is part of Kandi's strategic efforts to advance high-quality development initiatives.

Mr. Yu, a U.S. citizen, brings over 20 years of corporate management experience and has held senior leadership roles at several leading multinational corporations. His expertise spans the entire product lifecycle, from research and development to marketing, and includes managing multinational teams across regions, including the United States.

Before joining Kandi, Mr. Yu held the following key positions:

  • October 2020 - February 2024: Vice President, BoulderAI Technologies Co., Ltd., Hangzhou, China.
  • LTDOctober 2014 - July 2019: CTO and Vice President of Product Management, Huawei Enterprise Network (Silicon Valley).
  • October 2011 - October 2014: Senior Director and Chief Cloud Transformation and Network Architect, Global Marketing Solution Center for Operators, Huawei U.S. Research Institute (Silicon Valley).
  • June 2002 - October 2011: Chief Market Technology and Management Specialist, Edge Routing and Security Product Line, Hong Kong office of Cisco Systems Asia Pacific Headquarters.
  • April 1995 - May 2001: Senior Engineer, Edge Router R&D, Cisco Systems (Silicon Valley).

Mr. Yu holds a Master's degree in Computer Engineering from the University of California, Los Angeles, earned in June 1992, and an MBA from the University of Hong Kong, obtained in January 2011.

Concurrently, Johnny Tai will transition from his role as CEO of SC Autosports to Vice President, where he will focus on expanding the Company's dealer network.

Mr. Feng Chen, CEO of Kandi, commented, "We are delighted to welcome Mr. Bin Yu to the leadership team at SC Autosports. With his extensive experience and proven track record, I am confident he will drive our business to new heights by strengthening channel development and expanding our customer base, in line with Kandi's new growth strategy. We also express our gratitude to Johnny for his significant contributions as CEO and look forward to his continued efforts in building a more comprehensive and robust dealer network."

About Kandi Technologies Group, Inc.

Kandi Technologies Group, Inc. (KNDI), headquartered in Jinhua New Energy Vehicle Town,Zhejiang Province, is engaged in the research, development, manufacturing, and sales of various vehicular products. Kandi conducts its primary business operations through its wholly-owned subsidiary, Zhejiang Kandi Technologies Group Co., Ltd. ("Zhejiang Kandi Technologies"), formerly, Zhejiang Kandi Vehicles Co., Ltd. and its subsidiaries including Kandi Electric Vehicles (Hainan) Co., Ltd. and SC Autosports, LLC (d/b/a Kandi America), the wholly-owned subsidiary of Kandi in the United States, and its wholly-owned subsidiary, Kandi America Investment, LLC. Zhejiang Kandi Technologies has established itself as one of China's leading manufacturers of pure electric vehicle parts and off-road vehicles.

Safe Harbor Statement

This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on the SEC's website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the applicable securities laws, the Company does not assume a duty to update these forward-looking statements.

Follow us on Twitter: @ Kandi_Group

Contacts:

Kandi Technologies Group, Inc.
Ms. Kewa Luo
+1 (212) 551-3610
IR@kandigroup.com

The Blueshirt Group
Mr. Gary Dvorchak, CFA
gary@blueshirtgroup.co


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.